Important Notice: Limited Web Access Dec 16 to 18, 2016

AIChE will undertake a routine upgrade of our digital infrastructure over the weekend of December 16-18, 2016. During this period access to certain areas of the website will be limited. Additional information will be forthcoming shortly.

Qinjian Zhao

Qinjian Zhao

Xiamen University

Dr. Qinjian Zhao got his undergraduate and graduate training in pharmaceutical sciences in Peking University (1981 – 1989). Then he moved on to pursue a Ph.D. degree in Biochemistry in The Catholic University of America, Washington, DC (1989-1993).   Subsequently, he did post-doctoral training in School of Medicine, Johns Hopkins University (1993-1997), focusing on protein structure and enzyme function. In 1997, Qinjian joined Merck Research Lab, Bioprocess R&D, working on the analytical and structural aspects of recombinant protein based vaccines, such as Recombivax HB and HPV vaccine/Gardasil. In vitro relative potency assays and developing and characterizing key immunochemical reagents are the main area of expertise – in support of vaccine development. After ~14 years’ work at Merck (1997-2011), Dr. Zhao joined Xiamen University in 2011, as a distinguished professor associated with the state “Thousand Talent Program”, working on diagnostics and vaccine/biologics development.  Dr. Qinjian Zhao co-authored over 50 peer reviewed papers and 4 book chapters.